Cargando…

Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies

Purpose of this Review: This article is a systematic review on the influence pregnancy has on multiple sclerosis and the resulting impact of disease-modifying therapies. Findings: Multiple sclerosis predominantly affects young women with a clinical onset most often during the child-bearing age. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simone, Isabella Laura, Tortorella, Carla, Ghirelli, Alma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280312/ https://www.ncbi.nlm.nih.gov/pubmed/34276545 http://dx.doi.org/10.3389/fneur.2021.697974

Ejemplares similares

Editorial: Disease modifying therapies in multiple sclerosis
por: Bonavita, Simona, et al.
Publicado: (2022)

Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies
por: Simoens, Steven
Publicado: (2022)

The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician’s review
por: Kania, Karolina, et al.
Publicado: (2023)

Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapy
por: Melnikov, Mikhail, et al.
Publicado: (2022)

Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review
por: Capone, Fioravante, et al.
Publicado: (2022)

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
por: Claflin, Suzi B., et al.
Publicado: (2019)

Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies
por: Sgarlata, Eleonora, et al.
Publicado: (2022)

Multiple sclerosis and exercise—A disease-modifying intervention of mice or men?
por: Martin, Sarah-Jane, et al.
Publicado: (2023)

Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment
por: Jayaraman, Sundararajan, et al.
Publicado: (2022)

Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies
por: Bridge, Francesca, et al.
Publicado: (2023)

Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis
por: Lees, Samuel, et al.
Publicado: (2021)

Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis
por: Vollmer, Brandi L., et al.
Publicado: (2022)

Impact of Andropause on Multiple Sclerosis
por: Ysrraelit, Maria C., et al.
Publicado: (2021)

Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study
por: Al-Sakran, Lina, et al.
Publicado: (2019)

Pregnancy-related healthcare utilization among women with multiple sclerosis
por: Mainguy, Marie, et al.
Publicado: (2023)

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
por: Simone, Isabella Laura, et al.
Publicado: (2006)

Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know?
por: Cortese, Rosa, et al.
Publicado: (2022)

Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab—A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry
por: Guger, Michael, et al.
Publicado: (2020)

Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational study
por: Arroyo, Rafael, et al.
Publicado: (2017)

Optimizing the “Time to pregnancy” in women with multiple sclerosis: the OPTIMUS Delphi survey
por: Carbone, Luigi, et al.
Publicado: (2023)

Factors Influencing the Degree of Disability in Patients With Multiple Sclerosis
por: Xue, Huiru, et al.
Publicado: (2021)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis
por: Petrone, Linda, et al.
Publicado: (2022)

Influence of exercise on quantity and deformability of immune cells in multiple sclerosis
por: Proschmann, Undine, et al.
Publicado: (2023)

The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis
por: Pardo, Gabriel, et al.
Publicado: (2022)

Profiling morphologic MRI features of motor neuron disease caused by TARDBP mutations
por: Spinelli, Edoardo Gioele, et al.
Publicado: (2022)

Impact of aging on treatment considerations for multiple sclerosis patients
por: Macaron, Gabrielle, et al.
Publicado: (2023)

Opportunities and Obstacles Associated With Sequential Immune Reconstitution Therapy for Multiple Sclerosis: A Case Report
por: Garbo, Riccardo, et al.
Publicado: (2021)

Managing the transition (ManTra): a resource for persons with secondary progressive multiple sclerosis and their health professionals: protocol for a mixed-methods study in Italy
por: Giovannetti, Ambra Mara, et al.
Publicado: (2017)

Fine Particulate Matter Related to Multiple Sclerosis Relapse in Young Patients
por: Januel, Edouard, et al.
Publicado: (2021)

Association Between Body Mass Index and Response to Disease-Modifying Therapies in Patients With Relapsing-Remitting Multiple Sclerosis at King Abdulaziz University Hospital: A Retrospective Study
por: Aljehani, Mohammed N, et al.
Publicado: (2022)

Coagulation Pathways in Neurological Diseases: Multiple Sclerosis
por: Ziliotto, Nicole, et al.
Publicado: (2019)

Cognitive Impairment Impacts Exercise Effects on Cognition in Multiple Sclerosis
por: Rademacher, Annette, et al.
Publicado: (2021)

The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis
por: Motolese, Francesco, et al.
Publicado: (2020)

Sex-Specific Environmental Impacts on Initiation and Progression of Multiple Sclerosis
por: Leffler, Jonatan, et al.
Publicado: (2022)

Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis
por: Amoriello, Roberta, et al.
Publicado: (2022)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study
por: Fares, Jawad, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5aadef9703eq4u7pmc9p499soa